肌肉注射复方倍他米松后急性肌病：一例报告。
Acute myopathy following intra-muscular injection of compound betamethasone: A case report.
作者信息
Sun Li-Yuan, Chu Xiao-Ling
机构信息
Department of Dermatology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
出版信息
Medicine (Baltimore). 2017 Aug;96(34):e7474. doi: 10.1097/MD.0000000000007474.
RATIONALE
We report a case of acute steroid myopathy in a patient with eczema receiving one dose of intra-muscular injection of Compound betamethasone.
PATIENT CONCERNS
Acute steroid myopathy (ASM) is usually caused by exogenous corticosteroids, and typically, occurs with therapy using intravenous corticosteroids at high doses.
DIAGNOSES
The patient was considered as a diagnosis of acute steroid myopathy.
INTERVENTIONS
The patient was treated with non-steroid anti-inflammatory drug and other symptomatic therapy.
OUTCOMES
ASM was gradually improved after 2 weeks symptomatic treatment and completely recovered after one-month treatment.
LESSONS
The diagnosis of steroid myopathy is a clinical diagnosis based on characteristic symptoms. Higher dose of steroids, especially fluorinated steroids, for longer periods of time increases the risk of steroid-induced myopathy.
原理
我们报告了一例患有湿疹的患者在接受一剂复方倍他米松肌肉注射后发生急性类固醇肌病的病例。
患者情况
急性类固醇肌病（ASM）通常由外源性皮质类固醇引起，通常发生在高剂量静脉使用皮质类固醇治疗期间。
诊断
该患者被诊断为急性类固醇肌病。
干预措施
患者接受了非甾体抗炎药及其他对症治疗。
结果
经过2周的对症治疗，ASM逐渐改善，1个月治疗后完全康复。
经验教训
类固醇肌病的诊断是基于特征性症状的临床诊断。更高剂量的类固醇，尤其是含氟类固醇，使用较长时间会增加类固醇诱导肌病的风险。
Zotero 插件